Researchers at the Johns Hopkins Kimmel Cancer Center have developed an artificial intelligence (AI) driven liquid biopsy that analyzes genome wide patterns of cell free DNA (cfDNA) fragments circulating in the blood. The test examines how these…
Continue Reading
News Source: www.sciencedaily.com
Leave a Reply